Equashield Medical provides advanced, automated solutions to protect healthcare workers and facilities from the risks associated with hazardous drug exposure and contamination. The company has developed two major patented products: Equashield CSTD and Equashield Pro. Equashield CSTD is an airtight closed-system drug-transfer device that protects against occupational exposure to hazardous drugs. Equashield Pro is an automatic compounding system specially designed to handle multiple tasks simultaneously while using advanced proprietary image-processing algorithms to monitor and control all stages of the process.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Equashield Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 6, 2022
www.calcalistech.com
Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation | CTech
#Investment
Aug 25, 2022
www.prnewswire.com
Equashield's State-of-the-Art Manufacturing Complex Fulfilling Customer Orders at Record Pace